Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat
Shares of Agios Pharmaceuticals surged nearly 15% in premarket trading on Wednesday after the US Food and Drug Administration approved an expanded use
Shares of Agios Pharmaceuticals surged nearly 15% in premarket trading on Wednesday after the US Food and Drug Administration approved an expanded use
US stocks held steady on Christmas Eve, with the broad market opening virtually flat. The Dow edged marginally higher, while the Nasdaq Composite
Shares of Agios Pharmaceuticals surged nearly 15% in premarket trading on Wednesday after the US Food and Drug Administration approved an expanded use
Latin America’s steel industry is under increasing strain as surging imports from China squeeze local markets and stall growth, despite the region’s rising
Japanese analyst Angorou predicts XRP could reach 1,000 yen equivalent to $6.41 XRP ETFs logged 25 straight business days of inflows totaling $1.07
Shiba Inu declined 91.78% from 2021 peak as millionaire-making rally debates continue Vitalik Buterin burned 410 trillion tokens in 2021, community added minimal
Black Swan Capitalist founder urges investors focus on XRP fundamentals not speculation XRP declined 32% over three months to $1.92, tracking 7.36% annual
Rio Silver Inc. (‘Rio Silver’ or the ‘Company’) provides the following year-end update and shareholder letter from President and Chief Executive Officer Chris
// Not for distribution to the United States newswire services or for dissemination in the United States // Copper Quest Exploration Inc. (CSE:
VANCOUVER, BC / ACCESS Newswire / December 24, 2025 / Goldgroup Mining Inc. (‘Goldgroup‘ or the ‘Company‘) (TSX-V:GGA)(OTC:GGAZF). Further to the Company’s news